• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人及实验性肺动脉高压中的脂肪因子和代谢调节剂。

Adipokines and Metabolic Regulators in Human and Experimental Pulmonary Arterial Hypertension.

机构信息

Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

Harvard Medical School, Boston, MA 02215, USA.

出版信息

Int J Mol Sci. 2021 Feb 1;22(3):1435. doi: 10.3390/ijms22031435.

DOI:10.3390/ijms22031435
PMID:33535425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7867052/
Abstract

Pulmonary hypertension (PH) is associated with meta-inflammation related to obesity but the role of adipose tissue in PH pathogenesis is unknown. We hypothesized that adipose tissue-derived metabolic regulators are altered in human and experimental PH. We measured circulating levels of fatty acid binding protein 4 (FABP-4), fibroblast growth factor -21 (FGF-21), adiponectin, and the mRNA levels of FABP-4, FGF-21, and peroxisome proliferator-activated receptor γ (PPARγ) in lung tissue of patients with idiopathic PH and healthy controls. We also evaluated lung and adipose tissue expression of these mediators in the three most commonly used experimental rodent models of pulmonary hypertension. Circulating levels of FABP-4, FGF-21, and adiponectin were significantly elevated in PH patients compared to controls and the mRNA levels of these regulators and PPARγ were also significantly increased in human PH lungs and in the lungs of rats with experimental PH compared to controls. These findings were coupled with increased levels of adipose tissue mRNA of genes related to glucose uptake, glycolysis, tricarboxylic acid cycle, and fatty acid oxidation in experimental PH. Our results support that metabolic alterations in human PH are recapitulated in rodent models of the disease and suggest that adipose tissue may contribute to PH pathogenesis.

摘要

肺动脉高压(PH)与肥胖相关的代谢炎症有关,但脂肪组织在 PH 发病机制中的作用尚不清楚。我们假设在人类和实验性 PH 中,脂肪组织来源的代谢调节剂发生改变。我们测量了特发性 PH 患者和健康对照组循环中脂肪酸结合蛋白 4(FABP-4)、成纤维细胞生长因子 21(FGF-21)、脂联素的水平以及肺组织中 FABP-4、FGF-21 和过氧化物酶体增殖物激活受体γ(PPARγ)的 mRNA 水平。我们还评估了三种最常用的实验性肺动脉高压啮齿动物模型中这些介质在肺和脂肪组织中的表达。与对照组相比,PH 患者的循环 FABP-4、FGF-21 和脂联素水平显著升高,这些调节剂和 PPARγ 的 mRNA 水平在人类 PH 肺和实验性 PH 大鼠的肺中也显著升高。这些发现伴随着实验性 PH 中与葡萄糖摄取、糖酵解、三羧酸循环和脂肪酸氧化相关的脂肪组织基因的 mRNA 水平增加。我们的研究结果表明,人类 PH 中的代谢改变在疾病的啮齿动物模型中得到了重现,并提示脂肪组织可能有助于 PH 的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/b899596d234b/ijms-22-01435-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/544b4219c997/ijms-22-01435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/884e7eb2df8f/ijms-22-01435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/6133f4c85cf2/ijms-22-01435-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/2318512f1d80/ijms-22-01435-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/6674b10b40bf/ijms-22-01435-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/7b14d86fe977/ijms-22-01435-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/ea83bc36d19e/ijms-22-01435-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/b899596d234b/ijms-22-01435-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/544b4219c997/ijms-22-01435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/884e7eb2df8f/ijms-22-01435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/6133f4c85cf2/ijms-22-01435-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/2318512f1d80/ijms-22-01435-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/6674b10b40bf/ijms-22-01435-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/7b14d86fe977/ijms-22-01435-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/ea83bc36d19e/ijms-22-01435-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d908/7867052/b899596d234b/ijms-22-01435-g008.jpg

相似文献

1
Adipokines and Metabolic Regulators in Human and Experimental Pulmonary Arterial Hypertension.人及实验性肺动脉高压中的脂肪因子和代谢调节剂。
Int J Mol Sci. 2021 Feb 1;22(3):1435. doi: 10.3390/ijms22031435.
2
Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome.代谢综合征患者血清脂联素、脂肪细胞脂肪酸结合蛋白及成纤维细胞生长因子21水平的评估
Physiol Res. 2014;63(2):219-28. doi: 10.33549/physiolres.932602. Epub 2014 Jan 8.
3
Total Adiponectin, Adipocyte Fatty Acid Binding Protein, Fibroblast Growth Factor 21 and Proinflammatory Marker Levels During the Early Stage of Acute Pancreatitis--A Pilot Study.急性胰腺炎早期总脂联素、脂肪细胞脂肪酸结合蛋白、成纤维细胞生长因子21及促炎标志物水平——一项初步研究
Clin Lab. 2015;61(9):1119-28. doi: 10.7754/clin.lab.2015.141251.
4
Relationship of Selected Adipokines with Markers of Vascular Damage in Patients with Type 2 Diabetes.2型糖尿病患者中所选脂肪因子与血管损伤标志物的关系
Metab Syndr Relat Disord. 2018 Jun;16(5):246-253. doi: 10.1089/met.2017.0179. Epub 2018 May 2.
5
Fibroblast growth factor 21 attenuates hypoxia-induced pulmonary hypertension by upregulating PPARγ expression and suppressing inflammatory cytokine levels.成纤维细胞生长因子 21 通过上调过氧化物酶体增殖物激活受体 γ 的表达和抑制炎症细胞因子水平来减轻低氧诱导的肺动脉高压。
Biochem Biophys Res Commun. 2018 Oct 2;504(2):478-484. doi: 10.1016/j.bbrc.2018.09.004. Epub 2018 Sep 6.
6
PPARγ and TGFβ-Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys.过氧化物酶体增殖物激活受体 γ 和转化生长因子-β——肺和肾脏中代谢、炎症和纤维化的主要调节剂。
Int J Mol Sci. 2021 Sep 28;22(19):10431. doi: 10.3390/ijms221910431.
7
Relationship Between 12 Adipocytokines and Distinct Components of the Metabolic Syndrome.12 种脂肪细胞因子与代谢综合征不同组分的关系。
J Clin Endocrinol Metab. 2018 Mar 1;103(3):1015-1023. doi: 10.1210/jc.2017-02085.
8
Effect of pre-existing maternal obesity, gestational diabetes and adipokines on the expression of genes involved in lipid metabolism in adipose tissue.母体肥胖、妊娠糖尿病和脂肪因子对脂肪组织中脂质代谢相关基因表达的影响。
Metabolism. 2014 Feb;63(2):250-62. doi: 10.1016/j.metabol.2013.10.001. Epub 2013 Oct 24.
9
Correlation of serum vitamin D, adipose tissue vitamin D receptor, and peroxisome proliferator-activated receptor γ in women with gestational diabetes mellitus.妊娠期糖尿病妇女血清维生素 D、脂肪组织维生素 D 受体与过氧化物酶体增殖物激活受体 γ 的相关性。
Chin Med J (Engl). 2019 Nov 5;132(21):2612-2620. doi: 10.1097/CM9.0000000000000480.
10
Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation.HIV 感染患者的脂肪因子水平:脂联素 2 和脂肪酸结合蛋白 4 作为 HIV 和抗反转录病毒治疗相关脂肪组织炎症的可能标志物。
BMC Infect Dis. 2018 Jan 5;18(1):10. doi: 10.1186/s12879-017-2925-4.

引用本文的文献

1
Single-Cell and Spatial Transcriptomics Identified Fatty Acid-Binding Proteins Controlling Endothelial Glycolytic and Arterial Programming in Pulmonary Hypertension.单细胞和空间转录组学鉴定出控制肺动脉高压中内皮糖酵解和动脉编程的脂肪酸结合蛋白
Arterioscler Thromb Vasc Biol. 2025 May 22. doi: 10.1161/ATVBAHA.124.321173.
2
Age, comorbidity burden and late presentation are significant predictors of hospitalization length and acute respiratory failure in patients with influenza.年龄、合并症负担和晚期就诊是流感患者住院时间和急性呼吸衰竭的重要预测因素。
Sci Rep. 2024 Jul 6;14(1):15563. doi: 10.1038/s41598-024-66550-8.
3

本文引用的文献

1
Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension.肥胖、雌激素与脂肪组织功能障碍——对肺动脉高压的影响
Pulm Circ. 2020 Sep 18;10(3):2045894020952019. doi: 10.1177/2045894020952023. eCollection 2020 Jul-Sep.
2
Resistin family proteins in pulmonary diseases.抵抗素家族蛋白与肺部疾病。
Am J Physiol Lung Cell Mol Physiol. 2020 Sep 1;319(3):L422-L434. doi: 10.1152/ajplung.00040.2020. Epub 2020 Jun 17.
3
Activation of cardiac AMPK-FGF21 feed-forward loop in acute myocardial infarction: Role of adrenergic overdrive and lipolysis byproducts.
Single-cell and Spatial Transcriptomics Identified Fatty Acid-binding Proteins Controlling Endothelial Glycolytic and Arterial Programming in Pulmonary Hypertension.
单细胞和空间转录组学鉴定出控制肺动脉高压中内皮糖酵解和动脉编程的脂肪酸结合蛋白
bioRxiv. 2024 Apr 15:2024.02.11.579846. doi: 10.1101/2024.02.11.579846.
4
Adipokines in pulmonary hypertension: angels or demons?肺动脉高压中的脂肪因子:天使还是魔鬼?
Heliyon. 2023 Nov 17;9(11):e22482. doi: 10.1016/j.heliyon.2023.e22482. eCollection 2023 Nov.
5
Anti-Adipogenic and Anti-Obesity Effects of Gongmi Tea and Gongmi So Extract.贡米茶叶和贡米籽提取物的抗脂肪生成及抗肥胖作用
Prev Nutr Food Sci. 2023 Mar 31;28(1):21-29. doi: 10.3746/pnf.2023.28.1.21.
6
Skeletal Muscle Dysfunction in Experimental Pulmonary Hypertension.实验性肺动脉高压中的骨骼肌功能障碍。
Int J Mol Sci. 2022 Sep 18;23(18):10912. doi: 10.3390/ijms231810912.
7
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases.松弛素-2作为心血管疾病的潜在生物标志物
J Pers Med. 2022 Jun 21;12(7):1021. doi: 10.3390/jpm12071021.
8
Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases.成纤维细胞生长因子 21 在纤维化疾病中的研究进展。
Oxid Med Cell Longev. 2022 May 29;2022:5042762. doi: 10.1155/2022/5042762. eCollection 2022.
9
BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis.肺动脉高压患者的体重指数与治疗反应:一项荟萃分析。
Chest. 2022 Aug;162(2):436-447. doi: 10.1016/j.chest.2022.02.041. Epub 2022 Mar 3.
心肌梗死后心脏 AMPK-FGF21 正反馈回路的激活:去甲肾上腺素过驱动和脂肪分解副产物的作用。
Sci Rep. 2019 Aug 14;9(1):11841. doi: 10.1038/s41598-019-48356-1.
4
Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.代谢综合征加重左心疾病所致肺动脉高压。
Circ Res. 2019 Aug 2;125(4):449-466. doi: 10.1161/CIRCRESAHA.118.314555. Epub 2019 Jun 3.
5
FGF21 as Modulator of Metabolism in Health and Disease.成纤维细胞生长因子21作为健康与疾病中新陈代谢的调节因子
Front Physiol. 2019 Apr 17;10:419. doi: 10.3389/fphys.2019.00419. eCollection 2019.
6
Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.碳酸酐酶抑制减轻炎症和实验性肺动脉高压。
Am J Respir Cell Mol Biol. 2019 Oct;61(4):512-524. doi: 10.1165/rcmb.2018-0232OC.
7
Pulmonary Hypertension and Obesity: Focus on Adiponectin.肺动脉高压与肥胖:聚焦脂联素。
Int J Mol Sci. 2019 Feb 20;20(4):912. doi: 10.3390/ijms20040912.
8
Mutual promotion of FGF21 and PPARγ attenuates hypoxia-induced pulmonary hypertension.成纤维细胞生长因子 21 和过氧化物酶体增殖物激活受体 γ 的相互促进作用可减轻低氧诱导的肺动脉高压。
Exp Biol Med (Maywood). 2019 Mar;244(3):252-261. doi: 10.1177/1535370219828692. Epub 2019 Feb 2.
9
Fibroblast growth factor 21 attenuates hypoxia-induced pulmonary hypertension by upregulating PPARγ expression and suppressing inflammatory cytokine levels.成纤维细胞生长因子 21 通过上调过氧化物酶体增殖物激活受体 γ 的表达和抑制炎症细胞因子水平来减轻低氧诱导的肺动脉高压。
Biochem Biophys Res Commun. 2018 Oct 2;504(2):478-484. doi: 10.1016/j.bbrc.2018.09.004. Epub 2018 Sep 6.
10
A Receptor Activation Attenuates Hypertensive Cardiac Remodeling via Promoting Brown Adipose Tissue-Derived FGF21.一种受体的激活通过促进棕色脂肪组织来源的成纤维细胞生长因子 21 来减轻高血压性心脏重构。
Cell Metab. 2018 Sep 4;28(3):476-489.e5. doi: 10.1016/j.cmet.2018.06.013. Epub 2018 Jul 12.